| scholarly article | Q13442814 |
| P2093 | author name string | Riley Bove | |
| P2860 | cites work | A randomized trial of testosterone therapy in males with rheumatoid arthritis | Q71160663 |
| Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women | Q71441833 | ||
| Safety of hormone replacement therapy (HRT) in systemic lupus erythematosus (SLE) | Q72046809 | ||
| Increase in serum 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a possible marker of the androgen-mediated immunosuppressive activity exerted by cyclosporin A: preliminary results | Q72149862 | ||
| Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids | Q72767544 | ||
| Decreased testosterone levels in men with rheumatoid arthritis: effect of low dose prednisone therapy | Q72865327 | ||
| CD3+ CD8+ CTL activity within the human female reproductive tract: influence of stage of the menstrual cycle and menopause | Q73128694 | ||
| The immune response during the luteal phase of the ovarian cycle: a Th2-type response? | Q73134957 | ||
| Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women | Q73392020 | ||
| Do flares of systemic lupus erythematosus decline after menopause? | Q73426082 | ||
| Hormone replacement therapy and interrelation between serum interleukin-6 and body mass index in postmenopausal women: a population-based study | Q73555669 | ||
| Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation | Q73687511 | ||
| Profile of sex hormones in male patients with systemic lupus erythematosus | Q73922586 | ||
| The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years | Q75405962 | ||
| The effect of some steroids (testosterone propionate, desoxycorticosterone acetate and ascorbic acid, and 21-acetoxy delta-5-pregnenolone, artisone acetate, Wyeth) in rheumatoid arthritis | Q75579999 | ||
| Safety of hormonal replacement therapy in postmenopausal patients with systemic lupus erythematosus | Q77531343 | ||
| Hormonal profiles and immunological studies of male lupus in Taiwan | Q77838537 | ||
| Ovarian failure and flares of systemic lupus erythematosus | Q77873043 | ||
| RESULTS PROVIDED BY HETEROCHRONIC GRAFTS OF THE OVARIES IN THE STUDY OF THE HYPOTHALAMO-HYPOPHYSO-OVARIAN REGULATION OF SENILE RATS | Q78434413 | ||
| Clinical characteristics of patients with late-onset multiple sclerosis | Q80727953 | ||
| Menopause hormonal therapy in women with systemic lupus erythematosus | Q80974111 | ||
| Symptoms of multiple sclerosis in women in relation to sex steroid exposure | Q81491321 | ||
| Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women | Q81811404 | ||
| [Elderly onset rheumatoid arthritis] | Q84138861 | ||
| Dehydroepiandrosterone for systemic lupus erythematosus | Q24243533 | ||
| High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction | Q24799929 | ||
| Systemic Lupus Erythematosus in Males | Q33476416 | ||
| Systemic lupus erythematosus in the elderly: clinical and immunological characteristics | Q33563933 | ||
| Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study | Q33566054 | ||
| A randomised controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis | Q33566104 | ||
| Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis | Q33579417 | ||
| For and against: The male menopause--does it exist? | Q33816762 | ||
| Prospective study of factors influencing the onset of natural menopause | Q33855741 | ||
| The neuroendocrine physiology of female reproductive aging: An update | Q34069052 | ||
| Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial | Q34158711 | ||
| Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition--an analysis of FSH, oestradiol and inhibin | Q34336894 | ||
| Androgen levels in adult females: changes with age, menopause, and oophorectomy. | Q34411038 | ||
| Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus | Q34426622 | ||
| Estrogen and testosterone therapies in multiple sclerosis | Q34610594 | ||
| Testosterone treatment in multiple sclerosis: a pilot study | Q34628272 | ||
| Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis | Q35083316 | ||
| Sex hormones modulate brain damage in multiple sclerosis: MRI evidence | Q35485697 | ||
| Late onset systemic lupus erythematosus in southern Chinese | Q35547972 | ||
| Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. | Q35554437 | ||
| Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature | Q35938845 | ||
| Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study | Q35941063 | ||
| Late onset rheumatoid arthritis: clinical and laboratory comparisons with younger onset patients | Q36271215 | ||
| Timing within the menstrual cycle, sex, and the use of oral contraceptives determine adrenergic suppression of NK cell activity | Q36621650 | ||
| Early menopause and severity of rheumatoid arthritis in women older than 45 years | Q36633422 | ||
| Reproductive and menopausal factors and risk of systemic lupus erythematosus in women | Q36773713 | ||
| Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone | Q36841506 | ||
| Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials | Q37140905 | ||
| Total and unopposed estrogen exposure across stages of the transition to menopause | Q37175273 | ||
| Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis | Q49037220 | ||
| Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition | Q49125243 | ||
| Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. | Q50869770 | ||
| Gender differences and protective effects of testosterone in collagen induced arthritis in rats. | Q51739739 | ||
| Penile anthropometry in systemic lupus erythematosus patients. | Q53159745 | ||
| The effect of menopause on disease activity in systemic lupus erythematosus. | Q53249654 | ||
| Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. | Q53958684 | ||
| A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and the menstrual cycle | Q55016375 | ||
| The aging of the immune system | Q56879398 | ||
| Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging | Q56995376 | ||
| Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis | Q57623483 | ||
| Systemic Lupus Erythematosus in Men | Q57674741 | ||
| Anti–interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: A randomized, double-blind, placebo-controlled study | Q58042990 | ||
| Systemic lupus erythematosus: sex hormones in male patients | Q64051221 | ||
| Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus | Q67482142 | ||
| Androgen replacement therapy in male patients with rheumatoid arthritis | Q67897215 | ||
| [Lowering effect of estrogen replacement treatment on immunoglobulins in menopausal women] | Q68847832 | ||
| Abnormalities of sex hormones in men with systemic lupus erythematosus | Q69786369 | ||
| Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation | Q70407740 | ||
| Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity | Q70414689 | ||
| Multiple sclerosis after age 50 | Q70997850 | ||
| Demyelinating events in early multiple sclerosis have inherent severity and recovery | Q37180615 | ||
| Aging attenuates the pituitary response to gonadotropin-releasing hormone | Q37341844 | ||
| The effects of previous hysterectomy on lupus | Q37403071 | ||
| Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval | Q37439495 | ||
| Progesterone and ovulation across stages of the transition to menopause | Q37441305 | ||
| Changes in the immune system during menopause and aging | Q37762009 | ||
| Male menopause: is it a real clinical syndrome? | Q37776521 | ||
| Menopause and aging: changes in the immune system--a review. | Q37784916 | ||
| Early menopause is an independent predictor of rheumatoid arthritis | Q37942536 | ||
| Menopause in patients with autoimmune diseases | Q37961466 | ||
| The length of perimenopausal menstrual cycles increases later and to a greater degree than previously reported | Q38467016 | ||
| Sex hormones and rheumatoid arthritis: cause or effect relationships in a complex pathophysiology? | Q40472014 | ||
| Influence of sex, age, and menopausal state on the course of early rheumatoid arthritis. | Q40691132 | ||
| Hormonal and pregnancy relationships to rheumatoid arthritis: convergent effects with immunologic and microvascular systems | Q40925071 | ||
| Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls | Q41325967 | ||
| The clinical features of elderly-onset rheumatoid arthritis. A comparison with younger-onset disease of similar duration | Q41503475 | ||
| Evaluation of the hypothalamic-pituitary-gonadal axis in males with systemic lupus erythematosus. | Q42456890 | ||
| Androgenizing effects of cyclosporin A in rheumatoid arthritis | Q42475180 | ||
| Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study | Q43505242 | ||
| Is late-onset multiple sclerosis associated with a worse outcome? | Q43534192 | ||
| Bone mineral density, biochemical markers of bone turnover, and hormonal status in men with systemic lupus erythematosus. | Q43838804 | ||
| Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis | Q43937864 | ||
| Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism | Q43948914 | ||
| Antiproliferative-antiinflammatory effects of methotrexate and sex hormones on cultured differentiating myeloid monocytic cells (THP-1). | Q44061777 | ||
| Hormonal modulation of interleukin-6, tumor necrosis factor and associated receptor secretion in postmenopausal women | Q44150997 | ||
| Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones. | Q44204454 | ||
| Multiple sclerosis with very late onset | Q44323945 | ||
| Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis | Q44514299 | ||
| The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. | Q44694311 | ||
| Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. | Q44708828 | ||
| Effect of gender on late-onset multiple sclerosis | Q44916829 | ||
| Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus | Q45081882 | ||
| Gonadal hormones in men with rheumatoid arthritis--from onset through 2 years | Q46094333 | ||
| Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis | Q46191626 | ||
| Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition | Q46268812 | ||
| The medicalisation of male menopause in America | Q46498665 | ||
| Comparative studies on the interplay of testosterone, estrogen and progesterone in collagen induced arthritis in rats | Q46503351 | ||
| The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial | Q46557882 | ||
| Oral testosterone in male rats and the development of experimental autoimmune encephalomyelitis | Q46577364 | ||
| Monitoring reproductive aging in a 5-year prospective study: aggregate and individual changes in steroid hormones and menstrual cycle lengths with age. | Q46689656 | ||
| Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus | Q46780001 | ||
| Estrogen and other female reproductive risk factors are not strongly associated with the development of rheumatoid arthritis in elderly women | Q47376722 | ||
| Gonadal hormones influence the immune response to PLP 139-151 and the clinical course of relapsing experimental autoimmune encephalomyelitis | Q47969640 | ||
| Androgenizing effects of low-dose cyclosporin in male patients with early RA. | Q47994990 | ||
| Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function. | Q48179912 | ||
| Hormone replacement therapy in postmenopausal women with rheumatoid arthritis stabilises bone mineral density by digital x-ray radiogrammetry in a randomised controlled trial. | Q48537149 | ||
| The neuroendocrine axis in patients with multiple sclerosis | Q48691841 | ||
| Declining fecundity and ovarian ageing in natural fertility populations | Q48925972 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 251-264 | |
| P577 | publication date | 2013-02-28 | |
| P1433 | published in | Clinical Immunology | Q15752921 |
| P1476 | title | Autoimmune diseases and reproductive aging | |
| P478 | volume | 149 |
| Q46554198 | Age at natural menopause among patients with systemic lupus erythematosus. |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q55008522 | Association of serum testosterone and dehydroepiandrosterone sulfate with rheumatoid arthritis: a case control study. |
| Q64081204 | Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan |
| Q35215536 | Cardiovascular risk factor distribution and subjective risk estimation in urban women--the BEFRI study: a randomized cross-sectional study |
| Q59808939 | From Systemic Inflammation to Neuroinflammation: The Case of Neurolupus |
| Q34040802 | Gender differences in autoimmune disease |
| Q57816569 | Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease |
| Q34302567 | Low testosterone is associated with disability in men with multiple sclerosis |
| Q64283956 | Mechanisms of hypertension in autoimmune rheumatic diseases |
| Q38150224 | Menopause in multiple sclerosis: therapeutic considerations |
| Q38247180 | Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers |
| Q28079341 | Premature ovarian insufficiency: the context of long-term effects |
| Q35450239 | Puberty and perimenopause: reproductive transitions and their implications for women's health. |
| Q26738462 | Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art - part one |
| Q36054251 | Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis. |
| Q35509492 | Sex differences in inflammation during atherosclerosis |
| Q54977617 | Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease. |
| Q38190349 | The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis |
| Q102060892 | The role of sex hormones in women with Multiple Sclerosis: from puberty to assisted reproductive techniques |
| Q47201174 | The role of testosterone in MS risk and course |
Search more.